Missouri AG warns Lilly over 340B claims-data requirement

Missouri's attorney general has warned Eli Lilly to stop requiring hospitals to submit claims data as a condition for receiving discounted drugs under the 340B program. This escalates a legal and policy dispute over 340B contract pharmacy arrangements, potentially affecting drug pricing and hospital access. The outcome could set a precedent for other states and manufacturers.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works